Michael Barry
Impact in
- Virology top 0.5%
- HIV Research and Treatment
- Infectious Diseases top 0.5%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
Papers in
-
- Health Systems, Economic Evaluations, Quality of Life 60
- Pharmaceutical Economics and Policy 30
-
- HIV/AIDS drug development and treatment 34
- HIV/AIDS Research and Interventions 13
- Co-authors
- David Back (26 shared papers)Fiona Mulcahy (13 shared papers)András Veres (2 shared papers)Andrew T. Campbell (2 shared papers)Sara Gibbons (3 shared papers)Cathal Walsh (30 shared papers)Lesley Tilson (31 shared papers)J. Feely (16 shared papers)
- Journals
- Value in Health (26 papers)British Journal of Clinical Pharmacology (17 papers)PharmacoEconomics (9 papers)AIDS (8 papers)Clinical Infectious Diseases (6 papers)
- Partner nations
- IrelandUnited KingdomUnited States
In The Last Decade
Michael Barry
213 papers receiving 5.3k citations
Michael Barry's Hit Papers
Peers
Comparison fields: 5 of 162
- Virology 1.1k
- Infectious Diseases 1.8k
- Hepatology 402
- Pharmacology 437
- Emergency Medicine 443
Countries citing papers authored by Michael Barry
This map shows the geographic impact of Michael Barry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Barry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Barry more than expected).
Fields of papers citing papers by Michael Barry
This network shows the impact of papers produced by Michael Barry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Barry. The network helps show where Michael Barry may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Barry, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 219 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Natriuretic Peptide–Based Screening and Collaborative Care for Heart Failure Hit paper breakdown → | 2013 | 384 |
| 2 | 1997 | 281 | |
| 3 | 1999 | 224 | |
| 4 | 1997 | 216 | |
| 5 | 2001 | 211 | |
| 6 | 2002 | 198 | |
| 7 | 1999 | 170 | |
| 8 | 2002 | 169 | |
| 9 | 1997 | 159 | |
| 10 | 1997 | 116 | |
| 11 | 1999 | 115 | |
| 12 | 2001 | 115 | |
| 13 | 2016 | 86 | |
| 14 | 2001 | 81 | |
| 15 | 1996 | 75 | |
| 16 | 1999 | 71 | |
| 17 | 2003 | 64 | |
| 18 | 2011 | 63 | |
| 19 | 2012 | 62 | |
| 20 | 1990 | 62 |
About Michael Barry
Michael Barry is a scholar working on Economics and Econometrics, Infectious Diseases, Epidemiology, General Health Professions and Virology, having authored 219 papers that have together received 5.6k indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (60 papers), HIV/AIDS drug development and treatment (34 papers), Pharmaceutical Economics and Policy (30 papers), HIV Research and Treatment (24 papers), Pneumocystis jirovecii pneumonia detection and treatment (13 papers), HIV/AIDS Research and Interventions (13 papers), Healthcare cost, quality, practices (12 papers) and Hepatitis C virus research (11 papers). The work is most often cited by research in Virology (1.1k citations), Infectious Diseases (1.8k citations), Hepatology (402 citations), Pharmacology (437 citations) and Emergency Medicine (443 citations). Michael Barry has collaborated with scholars based in Ireland, United Kingdom and United States. Frequent co-authors include David Back, Fiona Mulcahy, András Veres, Andrew T. Campbell, Sara Gibbons, Cathal Walsh, Lesley Tilson, J. Feely, Máirín Ryan and Patrick G. Hoggard. Their work appears in journals such as Value in Health, British Journal of Clinical Pharmacology, PharmacoEconomics, AIDS and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.